Crossref
Therapeutic implication of CRISPR gene editing in Alzheimerbs disease
Neurology Letters · 01.02.2026 · 5 (1) · 1-11
DOI: 10.66224/nl.5.1.1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neurology Letters, online erschienen am 01.02.2026. Verfasst von Maria Belen Quiroga und 4 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Quiroga, M. B., Fernandez, J. I., Pereyra, L. A., Alvarez, S. M., & Rinaldi, C. S. (2026). Therapeutic implication of CRISPR gene editing in Alzheimerbs disease. Neurology Letters, 5(1), 1-11. https://doi.org/10.66224/nl.5.1.1
Vancouver
Quiroga MB, Fernandez JI, Pereyra LA, Alvarez SM, Rinaldi CS. Therapeutic implication of CRISPR gene editing in Alzheimerbs disease. Neurology Letters. 2026;5(1):1-11. doi:10.66224/nl.5.1.1
BibTeX
@article{Quiroga2026,
author = {Quiroga, Maria Belen and Fernandez, Juan Ignacio and Pereyra, Lucia Antonella and Alvarez, Santiago Martin and Rinaldi, Carolina Sofia},
title = {Therapeutic implication of CRISPR gene editing in Alzheimerbs disease},
journal = {Neurology Letters},
year = {2026},
volume = {5},
number = {1},
pages = {1--11},
doi = {10.66224/nl.5.1.1}
}
EUVIMED